Medicine and Dentistry
Lung
100%
Peptide
100%
Rapamycin-Insensitive Companion of mTOR
100%
Carcinogenesis
100%
Lung Cancer
76%
Patient
30%
Cancer Cell
30%
Non Small Cell Lung Cancer
23%
Tumor Progression
23%
Cell Death
23%
Protein Tertiary Structure
23%
Malignant Neoplasm
23%
Therapeutics
15%
Small Cell Lung Cancer
15%
Therapeutic Procedure
15%
Upregulation
7%
Death
7%
Neoplasm
7%
Personalized Medicine
7%
Regulatory Mechanism
7%
Phosphorylation
7%
Therapeutic Agent
7%
Cancer Incidence
7%
Tumor Suppressor Protein
7%
Gene
7%
Mammalian Target of Rapamycin Complex 2
7%
Mortality Rate
7%
Cancer Mortality
7%
Cells
7%
Protein Kinase B
7%
Development
7%
Pharmacology, Toxicology and Pharmaceutical Science
Rapamycin-Insensitive Companion of mTOR
100%
Peptide
100%
Carcinogenesis
100%
Lung Cancer
76%
Malignant Neoplasm
23%
Non Small Cell Lung Cancer
23%
Tumor Growth
23%
Cell Death
23%
Small Cell Lung Cancer
15%
Mammalian Target of Rapamycin Complex 2
7%
Cancer Mortality
7%
Death
7%
Cancer Incidence
7%
Mortality Rate
7%
Neoplasm
7%
Tumor Suppressor Protein
7%
Protein Kinase B
7%
Biochemistry, Genetics and Molecular Biology
Rapamycin-Insensitive Companion of mTOR
100%
Carcinogenesis
100%
Peptide
100%
Binding Domain
46%
Cancer Cell
30%
Tumor Progression
23%
Cell Death
23%
Mammalian Target of Rapamycin Complex 2
7%
Cancer Incidence
7%
Regulatory Mechanism
7%
Cancer Mortality
7%
Gene
7%
Mortality Rate
7%
Phosphorylation
7%
Upregulation
7%
Tumor Suppressor Protein
7%
Protein Kinase B
7%
Development
7%